Dr. Jha is a medical oncologist and hematologist focusing on solid tumor oncology including genito-urinary malignancies and head and neck tumors. Dr. Jha received his MBBS from the University of Mumbai, India. He also received a Master of Science, Pharmacology and Toxicology degree from the University of Rhode Island. Dr. Jha received internship and residency training at the Mount Sinai School of Medicine (Bronx, New York) and the University of Tennessee Health Sciences Center (Memphis). Dr. Jha began his fellowship in the Division of Hematology, Oncology and Transplantation at the University of Minnesota in 2007. He became a faculty member in the same Division in 2010.
Dr. Jha is interested in translational research and leading new drug development through phase I and II clinical trials. He is involved in developing improved immunotherapies for prostate cancer, and targeted therapies for head and neck and prostate cancers.
Banoglu E, Jha G, King RS. Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate. Eur J Drug Metab Pharmacokinet. 2001 Oct-Dec;26(4):235-40
Yuan ZX, Jha G, McGregor MA, King RS. Metabolites of the carcinogen 2-amino-alpha-carboline formed in male Sprague-Dawley rats in vivo and in rat hepatocyte and human HepG2 cell incubates. Chem Res Toxicol. 2007 Mar;20(3):497-503.
Milani M, Jha G, Potter DA. Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women. Clin Med Ther. 2009 Mar 31;1:141-156